GU Cancers 2018 | MRI-based prostate cancer diagnosis: economic and logistical considerations

The take-home message from the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, on MRI for prostate cancer diagnosis was positive. However, this leaves us with a variety of questions. In this interview, filmed at the meeting, Mark Emberton, MD, FRCS, of University College London, London, UK, gives us a concise and comprehensive summary of the economic and logistical issues with the use of MRI for prostate cancer diagnosis, including accessibility and changes to the previously straightforward diagnostic pathway.